SUN PHARMACEUTICAL INDUSTRIES
Back to Balance Sheet
|
SUN PHARMACEUTICAL INDUSTRIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹15,510 Cr | ₹13,046 Cr | ₹11,249 Cr | ₹11,439 Cr | ₹10,485 Cr |
What is the latest Sundry Debtors ratio of SUN PHARMACEUTICAL INDUSTRIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2026 | ₹15,510 Cr |
| Mar2025 | ₹13,046 Cr |
| Mar2024 | ₹11,249 Cr |
| Mar2023 | ₹11,439 Cr |
| Mar2022 | ₹10,485 Cr |
How is Sundry Debtors of SUN PHARMACEUTICAL INDUSTRIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2026 | ₹15,510 Cr | 18.88 | |
| Mar2025 | ₹13,046 Cr | 15.97 | |
| Mar2024 | ₹11,249 Cr | -1.65 | |
| Mar2023 | ₹11,439 Cr | 9.10 | |
| Mar2022 | ₹10,485 Cr | - | |
Compare Sundry Debtors of peers of SUN PHARMACEUTICAL INDUSTRIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,590.3 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| MANKIND PHARMA | ₹102,229.0 Cr | 6.8% | 4.6% | -6.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUN PHARMACEUTICAL INDUSTRIES | 1% |
-3.3% |
13.1% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses